SEC Company Response from ORAGENICS INC (OGEN) (CIK 0001174940) (OGEN) — May 4, 2018
ORAGENICS INC (OGEN) (CIK 0001174940)
Date: May 4, 2018 · CIK: 0001174940 · Accession: 0001193125-18-153023
AI Filing Summary & Sentiment
File numbers found in text: 333-224498
Show Raw Text
CORRESP 1 filename1.htm CORRESP Oragenics, Inc. 4902 Eisenhower Boulevard, Suite Tampa, Florida 33634 May 4, 2018 VIA EDGAR Ms. Christine Westbrook Division of Corporation Finance Office of Healthcare and Insurance United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-3628 Re: Oragenics, Inc. (the “Company”) Registration Statement on Form S-1 File No. 333-224498 Dear Ms. Westbrook: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date of the above referenced Registration Statement on Form S-1 be accelerated so that it will be declared effective at 4:00 p.m., Eastern Time, on Tuesday, May 8, 2018, or as soon thereafter as is practicable. We hereby authorize Mark A. Catchur of Shumaker, Loop & Kendrick, LLP, our outside legal counsel, to orally modify or withdraw this request of acceleration. Once the Registration Statement has been declared effective, please orally confirm that event with Mr. Catchur at (813) 227-2264. Thank you for your assistance in this matter. Very truly yours, By: /s/ Michael Sullivan Name: Michael Sullivan Title: Chief Financial Officer cc: Mark A. Catchur, Shumaker, Loop & Kendrick, LLP